Details for Patent: 7,365,205

Which drugs does patent 7,365,205 protect, and when does it expire?

Patent 7,365,205 protects SAVAYSA and is included in one NDA.

This patent has sixty patent family members in twenty-five countries.

Summary for Patent: 7,365,205

Title:	Diamine derivatives
Abstract:	A compound represented by the general formula (1): Q.sup.1-Q.sup.2-T.sup.0-N(R.sup.1)-Q.sup.3-N(R.sup.2)-T.sup.1-Q.sup.4 (1) wherein R.sup.1 and R.sup.2 are hydrogen atoms or the like; Q.sup.1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q.sup.2 is a single bond or the like; Q.sup.3 is a group ##STR00001## in which Q.sup.5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T.sup.0 and T.sup.1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
Inventor(s):	Ohta; Toshiharu (Tokyo, JP), Komoriya; Satoshi (Tokyo, JP), Yoshino; Toshiharu (Tokyo, JP), Nagamochi; Masatoshi (Tokyo, JP), Ono; Makoto (Tokyo, JP)
Assignee:	Daiichi Sankyo Company, Limited (Tokyo, JP)
Application Number:	10/481,262
Patent Claim Types: see list of patent claims	Compound;

Drugs Protected by US Patent 7,365,205

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Daiichi Sankyo Inc	SAVAYSA	edoxaban tosylate	TABLET;ORAL	206316-001	Jan 8, 2015		RX	Yes	No				Y
Daiichi Sankyo Inc	SAVAYSA	edoxaban tosylate	TABLET;ORAL	206316-002	Jan 8, 2015		RX	Yes	No				Y
Daiichi Sankyo Inc	SAVAYSA	edoxaban tosylate	TABLET;ORAL	206316-003	Jan 8, 2015		RX	Yes	Yes				Y

Foreign Priority and PCT Information for Patent: 7,365,205

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
Japan	2001-187105	Jun 20, 2001
Japan	2001-243046	Aug 9, 2001
Japan	2001-311808	Oct 9, 2001
Japan	2001-398708	Dec 28, 2001

PCT Information
PCT Filed	March 20, 2002	PCT Application Number:	PCT/JP02/02683
PCT Publication Date:	January 03, 2003	PCT Publication Number:	WO03/000657

International Family Members for US Patent 7,365,205

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	1405852		CA 2015 00052	Denmark
European Patent Office	1405852		92835	Luxembourg
European Patent Office	1405852		15C0068	France
European Patent Office	1405852		300760	Netherlands
European Patent Office	1405852		CR 2015 00052	Denmark